Myocardial Infarction News and Research

RSS

Viagra fights heart and lung diseases

German researchers have reported on the impact of Viagra on pulmonary hypertension at the Frontiers of Vascular Medicine Conference at Monash University this week.

30 Aug 2005

Statins reduce heart attack deaths by 50%

According to a U.S. study, giving a heart attack patient a statin drug as soon as possible reduces the chance he or she will die by 50 percent.

30 Aug 2005

Early statin therapy may be essential for reducing mortality and other complications in heart attack victims

In the largest clinical study of its kind, UCLA researchers found that early treatment with a statin drug within 24 hours of having a heart attack reduced in-hospital mortality rates by over 50 percent.

29 Aug 2005

Continued race and sex disparities heart attack care

Differences based on race and sex in treatment patterns for hospitalized American heart attack patients have remained unchanged over an eight-year period, despite improvements in quality of heart attack care during this time, Emory and Yale School of Medicine researchers write in the August 18 issue of New England Journal of Medicine.

28 Aug 2005

FDA Approves Aceon to reduce risk of cardiovascular mortality in patients with stable coronary artery disease

Solvay Pharmaceuticals and CV Therapeutics have announced that the U.S. Food and Drug Administration (FDA) has approved Aceon (perindopril erbumine) Tablets for the treatment of patients with stable coronary artery disease to reduce the risk of cardiovascular mortality or non-fatal myocardial infarction (MI).

24 Aug 2005

Some medical conditions increase risk for developing major depression while others do not

Those who feel sad and lack an interest in regular life activities for at least two weeks and qualify for a diagnosis of minor depression are six times as likely to develop major depression compared to those who don't have these symptoms, according to a longitudinal study on risks for depression.

22 Aug 2005

Slower care for heart attack patients treated after hours and on weekends

Heart attack patients treated with primary percutaneous intervention (PCI) at hospitals after hours and on weekends wait longer to receive clot busters and other treatments and have a higher risk of death than those treated during regular hospital hours

18 Aug 2005

Treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race

Despite a decade of initiatives to remedy health disparities in cardiovascular medicine, at least some aspects of the treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race, according to a study by researchers at Emory University in collaboration with Yale University and other centers.

17 Aug 2005

FDA approval for Diovan (Valsartan)

Novartis Pharmaceuticals Corporation announced today that the US Food and Drug Administration (FDA) approved Diovan (valsartan), the most prescribed ARB (angiotensin receptor blocker) in the US and worldwide, for a new indication to reduce cardiovascular death in patients at high risk (with left ventricular failure or left ventricular dysfunction) following a heart attack.

4 Aug 2005

Stem cell therapy can be used effectively to treat heart attacks, or myocardial infarction, in pigs

In just two months, stem cells harvested from another pig's bone marrow and injected into the animal's damaged heart restored heart function and repaired damaged heart muscle by 50 percent to 75 percent.

25 Jul 2005

Evaluating how hospitals deliver medical care standardizes practices and improves care

In recent years, American hospitals have made significant improvements on standardized, evidence-based measures of clinical performance for several medical conditions, including heart attacks, heart failure, and pneumonia.

20 Jul 2005

Quality of care in U.S. hospitals

Ashish Jha, assistant professor of health policy and management at the Harvard School of Public Health and colleagues from Brigham and Women's Hospital and the Boston Veterans Affairs Healthcare System, have for the first time assessed the quality of care in U.S. hospitals.

20 Jul 2005

Insulin resistance increases a person's risk for development of congestive heart failure

Congestive heart failure (CHF) is a major cause of illness and death, according to background information in the article. The death rate for patients with CHF is 4 to 8 times that of the general population. The predominant causes of heart failure are hypertension and coronary heart disease.

19 Jul 2005

Abnormal heart rate variability is partially responsible for depression's effects in heart patients

Scientists have known for years that depression increases the risk of dying in the months after a heart attack, but they haven't understood how depression raises that risk.

13 Jul 2005

Medicare's investment in quality improvement may not be paying off

Medicare's quality improvement organizations are charged with improving the medical care of Medicare beneficiaries.

14 Jun 2005

Invasive treatment including stenting may be more effective for heart attack patients who arrive late at hospital

Invasive treatment including stenting may have better outcomes than conventional treatments for heart attack patients who arrive at the hospital more than 12 hours after symptoms began, according to a study in the June 15 issue of JAMA.

14 Jun 2005

Fish oil does not lower risk of serious heart rhythm abnormalities for patients with implantable defibrillators

Even though previous research has shown that fatty acids from fish oil reduce the risk of sudden cardiac death, patients with implantable defibrillators who took fish oil supplements did not see a reduction in serious heart rhythm abnormalities, according to a study in the June 15 issue of JAMA: The Journal of the American Medical Association.

14 Jun 2005

Myocardial Infarction News and Research

Viagra fights heart and lung diseases

Statins reduce heart attack deaths by 50%

Early statin therapy may be essential for reducing mortality and other complications in heart attack victims

Continued race and sex disparities heart attack care

FDA Approves Aceon to reduce risk of cardiovascular mortality in patients with stable coronary artery disease

Some medical conditions increase risk for developing major depression while others do not

Slower care for heart attack patients treated after hours and on weekends

Treatment of U.S. patients hospitalized for heart attacks continues to vary according to sex and race

FDA approval for Diovan (Valsartan)

Stem cell therapy can be used effectively to treat heart attacks, or myocardial infarction, in pigs

Evaluating how hospitals deliver medical care standardizes practices and improves care

Quality of care in U.S. hospitals

Insulin resistance increases a person's risk for development of congestive heart failure

Abnormal heart rate variability is partially responsible for depression's effects in heart patients

Medicare's investment in quality improvement may not be paying off

Invasive treatment including stenting may be more effective for heart attack patients who arrive late at hospital

Fish oil does not lower risk of serious heart rhythm abnormalities for patients with implantable defibrillators

CalbaTech subsidiary files patent for stem cell delivery device

Ibruprofen and other commonly used painkillers for treating inflammation may increase the risk of heart attack

Commonly used painkillers for treating inflammation may increase the risk of heart attack

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News